| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $82,195,593 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172487 | Broadly neutralizing antibody combinations with single virions in HIV+ plasma | 000 | 4 | NIH | 12/19/2025 | $386,250 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI183599 | Genomic surveillance for artemisinin resistance in Africa: moving beyond a candidate gene approach | 001 | 2 | NIH | 1/16/2026 | $45,339 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI183599 | Genomic surveillance for artemisinin resistance in Africa: moving beyond a candidate gene approach | 000 | 2 | NIH | 1/14/2026 | $714,997 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172827 | Multi-Omics Characterization of Plasmodium Vivax Hypnozoites | 001 | 4 | NIH | 1/8/2026 | $121,824 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS141786 | SGLT2 - Novel Molecular Mechanism of AQP4 Regulation | 000 | 1 | NIH | 3/5/2026 | $602,065 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS117102 | Stem Cell Surface Modification to Promote Nerve Regeneration | 000 | 5 | NIH | 12/18/2025 | $386,953 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL172364 | Modulating the resolution of angiogenesis and normalization of the vasculature for therapeutic benefit | 001 | 2 | NIH | 5/1/2026 | $16,526 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM145806 | Molecular Physiology of Mitochondrial Calcium Uniporter | 000 | 4 | NIH | 4/9/2026 | $339,900 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | RF1AG059651 | PROMIS Profile Measures for Older Adults with Cognitive Impairment-Developing Versions for Older Adults with Cognitive Impairment and for Proxy Completion | 000 | 6 | NIH | 4/29/2026 | $3,284,905 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM131710 | Macromolecular Conformational Heterogeneity | 000 | 8 | NIH | 4/29/2026 | $746,909 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32GM136561 | Medical Scientist Training Program | 001 | 7 | NIH | 4/30/2026 | $707,005 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL149926 | Next generation calcium channel modulators | 001 | 7 | NIH | 3/30/2026 | $22,479 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM156369 | Conformational Dynamics and Regulatory Mechanisms in the KCNH Family of Ion Channels | 001 | 2 | NIH | 3/13/2026 | $42,762 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS131223 | The role of NPRL2 loss in focal cortical dysplasia | 000 | 4 | NIH | 4/6/2026 | $386,250 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI192916 | Shark nanobodies identify pan-coronavirus spike sites of vulnerability fortherapeutic intervention | 000 | 1 | NIH | 5/6/2026 | $896,045 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U54CA272205 | University of Maryland FIRST Program | 000 | 4 | NIH | 4/6/2026 | $4,630,507 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI196307 | Modeling the Vaginal Microbiome: Predicting BV Recurrence and Identifying Preventative Targets | 000 | 1 | NIH | 4/6/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 001 | 4 | NIH | 3/13/2026 | $16,798 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99CA312671 | Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparison | 000 | 1 | NIH | 5/7/2026 | $123,823 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 000 | 5 | NIH | 4/6/2026 | $613,747 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | The development a new Multidimensional and Multilevel Measure of Institutional and Economic Barriers for English and Spanish speaking populations | 001 | 4 | NIH | 4/24/2026 | $3,078 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F32AI200207 | Menstrual phase targeted therapy: a novel strategy to improve clearance and reduce recurrence of bacterial vaginosis | 000 | 1 | NIH | 5/7/2026 | $79,764 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI196697 | A cord-blood specific subset of human gamma-delta T cells with distinct functional features | 000 | 1 | NIH | 2/3/2026 | $455,500 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 001 | 4 | NIH | 3/27/2026 | $65,182 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK074797 | Inter-organ signaling in heme metabolism and organismal homeostasis. | 000 | 15 | NIH | 12/30/2025 | $397,410 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 000 | 3 | NIH | 12/22/2025 | $558,043 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA065079 | Impact of opioid use disorder on mitochondrial dysfunction among antiretroviral therapy-receiving aging people with HIV. | 000 | 1 | NIH | 3/10/2026 | $685,937 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI036525 | Immune Mechanisms of Protection in Salmonella Infection in Humans | 000 | 25 | NIH | 3/27/2026 | $2,783,014 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI190371 | Multi-omics Analysis of Bacteria-Host Interactions in Brugia malayi, a Medically Important Nematode with a Wolbachia Endosymbiont | 000 | 1 | NIH | 3/27/2026 | $678,218 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG076441 | Recovery among Older Adults Following Head Injury | 000 | 5 | NIH | 3/27/2026 | $637,910 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH139606 | Quantifying cerebellar multi-omic and synaptic features of autism spectrum disorders | 000 | 1 | NIH | 3/9/2026 | $762,566 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA039062 | Endocannabinoids regulate microglia in developing brain | 000 | 10 | NIH | 2/27/2026 | $469,533 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073136 | Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | 000 | 5 | NIH | 2/27/2026 | $509,641 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011811 | Eastern Nigeria Research Ethics Training (ENRICH) Program | 000 | 5 | NIH | 2/27/2026 | $192,247 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AA024845 | Striatal Microcircuit Dynamics of Ethanol Habits | 000 | 9 | NIH | 2/27/2026 | $440,826 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD093070 | VEGF Gene Delivery In The Primate To Prevent Defective Spiral Artery Remodeling And Maternal Vascular Dysfunction | 001 | 8 | NIH | 3/27/2026 | $663,053 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081693 | Deep-Learning Enhanced ASL MRI For Early AD Assessment | 001 | 3 | NIH | 2/23/2026 | $75,852 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS045585 | Role of microglial phagocytosis in prion diseases | 000 | 23 | NIH | 3/3/2026 | $617,991 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR077563 | Molecular Determinants of Pigmentation (MDoP) | 000 | 5 | NIH | 2/26/2026 | $435,440 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA273216 | Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer | 001 | 5 | NIH | 4/16/2026 | $64,611 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08AI170950 | Characterization of seasonal CoV immunity and operationalization of a novel controlled human infection model for the betacoronavirus OC43 | 000 | 4 | NIH | 4/17/2026 | $132,392 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 001 | 3 | NIH | 4/17/2026 | $64,113 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 001 | 3 | NIH | 4/16/2026 | $62,004 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA292106 | Chemotherapy induced MASP activation and ovarian cancer metastasis | 001 | 2 | NIH | 4/16/2026 | $46,217 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA063090 | Joint decomposition of SCORCH mulit-omic data to explore the impact of SUD and HIV on reward circuitry and neuroinflammation | 001 | 2 | NIH | 4/17/2026 | $542,412 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31MH136797 | Structural, Functional, and Neurobehavioral Consequences of Adolescent COVID-19 | 000 | 3 | NIH | 4/16/2026 | $37,269 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH139635 | Endocannabinoid Control of Cholinergic Transmission and the Pursuit of Reward | 000 | 2 | NIH | 3/19/2026 | $671,643 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA063051 | Behavioral and neurobiological mechanisms of reciprocal social interactions in Substance Use Disorders | 000 | 2 | NIH | 3/19/2026 | $641,450 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA298839 | Tumor-associated pDC (TApDC) in liver cancer with HIV infection | 001 | 2 | NIH | 4/16/2026 | $63,406 |
|
